<Record>
<Term>Apolipoprotein B Hypobetalipoproteinemia, Familial</Term>
<SemanticType>Disease or Syndrome</SemanticType>
<ParentTerm>Hypobetalipoproteinemias</ParentTerm>
<ClassificationPath>Nutritional and Metabolic Diseases/Metabolic Diseases/Lipid Metabolism Disorders/Dyslipidemias/Hypolipoproteinemias/Hypobetalipoproteinemias/Hypobetalipoproteinemia, Familial, Apolipoprotein B</ClassificationPath>
<BroaderTerm>Lipid Metabolism Disorders</BroaderTerm>
<BroaderTerm>Metabolic Diseases</BroaderTerm>
<BroaderTerm>Nutritional and Metabolic Diseases</BroaderTerm>
<BroaderTerm>Hypolipoproteinemias</BroaderTerm>
<BroaderTerm>Dyslipidemias</BroaderTerm>
<BroaderTerm>Hypobetalipoproteinemias</BroaderTerm>
<BroaderTerm>Hypobetalipoproteinemia, Familial, Apolipoprotein B</BroaderTerm>
<Synonym>Apolipoprotein B Deficiency</Synonym>
<Synonym>Apolipoprotein B Deficiencies</Synonym>
<Synonym>Apolipoprotein B Deficiency Disease</Synonym>
<Description>An autosomal dominant disorder of lipid metabolism. It is caused by mutations of APOLIPOPROTEINS B, main components of CHYLOMICRONS and BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include abnormally low LDL, normal triglyceride level, and dietary fat malabsorption.</Description>
<Source>MeSH</Source>
</Record>
